ALIMERA SCIENCES, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 1st, 2008 • Alimera Sciences Inc • Delaware
Contract Type FiledJuly 1st, 2008 Company JurisdictionThis Indemnification Agreement (“Agreement”) is made as of by and between Alimera Sciences, Inc. a Delaware corporation (the “Company”), and [ ] (“Indemnitee”).
EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC.Employment Agreement • July 1st, 2008 • Alimera Sciences Inc • Georgia
Contract Type FiledJuly 1st, 2008 Company JurisdictionThis is an Employment Agreement entered into between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and Richard S. Eiswirth Jr. (“Executive”).
OFFICE LEASE RUBICON IN WINDWARD 6120 WINDWARD PARKWAY ALPHARETTA, GEORGIA 30005Office Lease • July 1st, 2008 • Alimera Sciences Inc • Georgia
Contract Type FiledJuly 1st, 2008 Company JurisdictionThis agreement (“Lease”), made and entered into as of this 27 day of May, 2003, by and between Rubicon, L.C., a Georgia limited liability company (“Landlord”) and Alimera Sciences, Inc. (“Tenant”);
ALIMERA SCIENCES, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 17, 2008Investor Rights Agreement • July 1st, 2008 • Alimera Sciences Inc • Delaware
Contract Type FiledJuly 1st, 2008 Company JurisdictionTHIS SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of this 17th day of March, 2008, by and among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Series A Preferred Stock (the “Series A Stock”) listed on Exhibit A attached hereto (the “Series A Investors”), the holders of the Company’s Series B Preferred Stock (the “Series B Stock”) listed on Exhibit B attached hereto (the “Series B Investors”), the holders of the Company’s Series C Preferred Stock (the “Series C Stock”) listed on Exhibit C attached hereto (the “Series C Investors”), those holders of the Company’s Common Stock listed on Exhibit D attached hereto (the “Common Holders”), and those holders of stock purchase warrants (the “Warrants”) to purchase shares of the Company’s Common Stock listed on Exhibit E attached hereto (the “Warrant Holders”). The Series A Stock, the Series B Stock and the Series C Stock, together shall be referred to h
EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC.Employment Agreement • July 1st, 2008 • Alimera Sciences Inc • Georgia
Contract Type FiledJuly 1st, 2008 Company JurisdictionThis is an Employment Agreement entered into between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and Dan Myers (“Executive”).
Alimera Sciences, Inc. 2008 Equity Incentive Plan (As Adopted Effective on the IPO Date)2008 Equity Incentive Plan • July 1st, 2008 • Alimera Sciences Inc
Contract Type FiledJuly 1st, 2008 Company
EMPLOYMENT AGREEMENT WITH ALIMERA SCIENCES, INC.Employment Agreement • July 1st, 2008 • Alimera Sciences Inc • Georgia
Contract Type FiledJuly 1st, 2008 Company JurisdictionThis is an Employment Agreement entered into between Alimera Sciences, Inc., a Delaware corporation (the “Company”), and David Holland (“Executive”).
ALIMERA SCIENCES, INC. SECOND AMENDED AND RESTATED STOCK SALE AGREEMENTStock Sale Agreement • July 1st, 2008 • Alimera Sciences Inc • Delaware
Contract Type FiledJuly 1st, 2008 Company JurisdictionTHIS SECOND AMENDED AND RESTATED STOCK SALE AGREEMENT (the “Agreement”) is made this 17th day of March, 2008, by and among Alimera Sciences, Inc., a Delaware corporation (the “Company”), the holders of the Company’s Common Stock, par value $0.01 per share (the “Common Stock”), listed on the Schedule of Common Holders attached as Exhibit A hereto (the “Common Holders”), the holders of the Company’s Series A Preferred Stock, par value $0.01 per share (the “Series A Stock”), listed on Exhibit B attached hereto (the “Series A Investors”), the holders of the company’s Series B Preferred Stock, par value $0.01 share (the “Series B Stock”), listed on Exhibit C hereto (the “Series B Investors”) and the holders of the Company’s Series C Preferred Stock, par value $0.01 per share (the “Series C Stock”, and together with the Series A Stock and Series B Stock, the “Preferred Stock”), listed on Exhibit D attached hereto (the “Series C Investors” and, together with the Series A Investors and the Ser